1 study on Bcl 2 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights MOTS-c as a novel and potent regulator of NASH progression, acting through a direct interaction with Bcl-2 to mitigate hepatic steatosis, inflammation, and fibrosis. The findings underscore th…